Mifamurtide Sodium Hydrate
米伐木肽钠
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NameMifamurtide Sodium Hydrate
Drug Alias Name +[14]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2009/03/06
Country/Territory +[4]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesTakeda France Sas
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)Exact Therapeutics AS
Active Indications
Inactive Indications